Apellis Pharmaceuticals Inc APLS Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	760.22M	978.87M	915.58M	818.22M	788.73M	831.93M	904.48M	901.87M
Total Current Assets	719.52M	954.26M	892.69M	796.77M	766.33M	811.43M	859.97M	833.9M
Cash and Equivalents	551.8M	765.08M	616.26M	452.41M	351.19M	325.92M	360.09M	396.86M
Total Non-Current Assets	40.69M	24.61M	22.89M	21.45M	22.4M	20.5M	44.51M	67.97M
Total Liabilities	590.35M	566.75M	570.18M	585.95M	594.21M	565.25M	640.16M	664.75M
Total Current Liabilities	167.61M	138.64M	174.84M	185.63M	247.59M	215.29M	169.17M	191.26M
Total Non-Current Liabilities	515.47M	520.91M	488.22M	493.27M	439.65M	443.07M	928.2M	925.73M
Common Equity	11k	12k	12k	12k	12k	12k	12k	12k
Retained Earnings	-2.31B	-2.49B	-2.61B	-2.75B	-2.84B	-2.9B	-2.94B	-3B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	27.43M	182.13M	203.53M	389.25M	960.57M	881.77M	760.22M	788.73M
Total Current Assets	27.37M	182.02M	202.44M	373.1M	917.19M	824.05M	719.52M	766.33M
Cash and Equivalents	24.86M	175.64M	176.27M	351.99M	565.78M	640.19M	551.8M	351.19M
Total Non-Current Assets	23.79M	148.94M	160.97M	34.23M	204.56M	198.66M	169.87M	194.52M
Total Liabilities	3.64M	33.19M	42.56M	355.02M	756.01M	683.1M	590.35M	594.21M
Total Current Liabilities	3.64M	6.55M	17.03M	65.75M	128.33M	131.85M	167.61M	247.59M
Total Non-Current Liabilities	0	53.02M	50.91M	431.83M	986.52M	740.28M	515.47M	439.65M
Total Equity	23.79M	148.94M	160.97M	34.23M	204.56M	198.66M	169.87M	194.52M
Common Equity	92.06M	5k	6k	6k	8k	10k	11k	12k
Retained Earnings	-98.26M	-149.26M	-276.77M	-581.47M	-926.35M	-1.66B	-2.31B	-2.84B